Inventor · Bound Brook, NJ, US

William Strohl

31Patents
7h-index
51Co-inventors
72Inventor score

Filing activity: May 24, 1996 → Sep 17, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US8961967B2 Antibody Fc mutants with ablated effector functions Chemistry; Metallurgy 26 Active
US7700099B2 Non-immunostimulatory antibody and compositions containing the same Emerging Cross-Sectional Technologies 17 Active
US7780963B2 Anti-ADDL antibodies and uses thereof Physics 14 Active
US9644023B2 Compositions and methods for phagocyte delivery of anti-staphylococcal agents Physics 13 Active
US10053513B2 Antibody Fc mutants with ablated effector functions Chemistry; Metallurgy 12 Active
US8871204B2 Active protease-resistant antibody FC mutants Chemistry; Metallurgy 8 Active
US7754213B2 High affinity antibody antagonists of interleukin-13 receptor alpha 1 Chemistry; Metallurgy 7 Active
US10894836B2 Antibody Fc mutants with ablated effector functions Chemistry; Metallurgy 6 Active
US9637549B2 Antibody Fc mutants with ablated effector functions Chemistry; Metallurgy 6 Active
US8785605B2 Humanized IL-25 antibodies Chemistry; Metallurgy 4 Active
US5976830A Methods of producing doxorubicin Chemistry; Metallurgy 3 Expired
US7811563B2 Anti-addl antibodies and uses thereof Physics 3 Active
US9371388B2 High affinity antibody antagonists of interleukin-13 receptor alpha 1 Chemistry; Metallurgy 2 Active
US7294646B2 Maxi-k channel blockers, methods of use and process for making the same Chemistry; Metallurgy 2 Expired
US7731962B2 Anti-ADDL monoclonal antibody and use thereof Physics 2 Active
US8568722B2 High affinity antibody antagonists of interleukin-13 receptor alpha 1 Chemistry; Metallurgy 2 Active
US8128930B2 Anti-ADDL antibodies and uses thereof Physics 1 Active
US5962293A Methods of producing doxorubicin Chemistry; Metallurgy 1 Expired
US9777062B2 High affinity antibody antagonists of interleukin-13 receptor alpha 1 Chemistry; Metallurgy 1 Active
US8889138B2 Anti-ADDL antibodies and uses thereof Physics 1 Active
US8613925B2 Anti-IL-13Rα1 antibodies and their uses thereof Chemistry; Metallurgy 1 Active
US8383113B2 Anti-ADDL antibodies and uses thereof Physics 1 Active
US11096998B2 Chimeric antigen receptors comprising BCMA-specific fibronectin type III domains and uses thereof Chemistry; Metallurgy 0 Active
US8105593B2 Anti-ADDL monoclonal antibody and use thereof Physics 0 Active
US10913784B2 RAGE fusion proteins with improved stability and ligand binding affinity and uses thereof Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.